Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries  healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
IPO Year:
Exchange: NYSE
Website: ventasreit.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/7/2025 | Hold → Buy | Argus | |
| 1/17/2025 | $66.00 → $65.00 | Neutral → Outperform | Robert W. Baird |
| 10/1/2024 | $61.00 → $71.00 | Equal Weight → Overweight | Wells Fargo |
| 3/18/2024 | $50.00 | In-line → Outperform | Evercore ISI |
| 2/26/2024 | $52.00 → $46.00 | Overweight → Equal Weight | Wells Fargo |
| 1/30/2024 | $60.00 | Buy | Deutsche Bank |
| 1/16/2024 | $48.00 → $53.00 | Neutral → Buy | BofA Securities |
| 11/7/2023 | $44.00 → $51.00 | Neutral → Outperform | Wedbush |
| 10/11/2023 | $47.00 | Outperform | Exane BNP Paribas |
| 10/3/2023 | $44.00 | Neutral | Wedbush |